CLINICAL_TRIALS
research
· 2026-03-25
Clinical Trial Update: A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease [Phase 1, Phase 2]
Summary
A clinical trials.gov entry describes a Phase 1/2 study of Yiyang Huoluo Decoction for coronary heart disease, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xia Liang | Conditions: Coronary Heart Disease, Coronary Artery Disease | Phase 1, Phase 2 | Status: RECRUITING